Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Chierigo

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
The Prostate|June 2, 2022
Rates of metastatic prostate cancer in newly diagnosed patients: Numbers needed to image according to risk levelGabriele Sorce, Benedikt Hoeh, Rocco S Flammia, et al.
International Urology and Nephrology|May 4, 2022
Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicityFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
The Prostate|February 21, 2022
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groupsBenedikt Hoeh, Christoph Würnschimmel, Rocco Simone Flammia, et al.
The Prostate|February 21, 2022
Non-organ confined stage and upgrading rates in exclusive PSA high-risk prostate cancer patientsBenedikt Hoeh, Rocco S Flammia, Lukas Hohenhorst, et al.
International Journal of Impotence Research|August 19, 2025
Systematic review of the outcomes of urethroplasty following urethral lengthening in transgender menPaul Neuville, François-Xavier Madec, Malte W Vetterlein, et al.
Critical Reviews in Oncology/Hematology|July 25, 2025
Emerging biomarkers in bladder cancer: Translating molecular advances into precision oncologyMatteo Ferro, Felice Crocetto, Letizia Maria Ippolita Jannello, et al.
Central European Journal of Urology|July 24, 2023
The association of the type and number of D'Amico high-risk criteria with rates of pathologically non-organ-confined prostate cancerFrancesco Chierigo, Rocco Simone Flammia, Gabriele Sorce, et al.
Cancers|July 12, 2025
Interpretation of PSMA-PET Among Urologists: A Prospective Multicentric EvaluationGuglielmo Mantica, Francesco Chierigo, Francesca Ambrosini, et al.
Journal of Surgical Oncology|June 6, 2022
Outcomes of robotic-assisted versus open radical cystectomy in a large-scale, contemporary cohort of bladder cancer patientsBenedikt Hoeh, Rocco S Flammia, Lukas Hohenhorst, et al.
Cancers|March 10, 2022
Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical CystectomyBenedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
The Prostate|June 2, 2022
Rates of metastatic prostate cancer in newly diagnosed patients: Numbers needed to image according to risk levelGabriele Sorce, Benedikt Hoeh, Rocco S Flammia, et al.
International Urology and Nephrology|May 4, 2022
Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicityFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
The Prostate|February 21, 2022
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groupsBenedikt Hoeh, Christoph Würnschimmel, Rocco Simone Flammia, et al.
The Prostate|February 21, 2022
Non-organ confined stage and upgrading rates in exclusive PSA high-risk prostate cancer patientsBenedikt Hoeh, Rocco S Flammia, Lukas Hohenhorst, et al.
International Journal of Impotence Research|August 19, 2025
Systematic review of the outcomes of urethroplasty following urethral lengthening in transgender menPaul Neuville, François-Xavier Madec, Malte W Vetterlein, et al.
Critical Reviews in Oncology/Hematology|July 25, 2025
Emerging biomarkers in bladder cancer: Translating molecular advances into precision oncologyMatteo Ferro, Felice Crocetto, Letizia Maria Ippolita Jannello, et al.
Central European Journal of Urology|July 24, 2023
The association of the type and number of D'Amico high-risk criteria with rates of pathologically non-organ-confined prostate cancerFrancesco Chierigo, Rocco Simone Flammia, Gabriele Sorce, et al.
Cancers|July 12, 2025
Interpretation of PSMA-PET Among Urologists: A Prospective Multicentric EvaluationGuglielmo Mantica, Francesco Chierigo, Francesca Ambrosini, et al.
Journal of Surgical Oncology|June 6, 2022
Outcomes of robotic-assisted versus open radical cystectomy in a large-scale, contemporary cohort of bladder cancer patientsBenedikt Hoeh, Rocco S Flammia, Lukas Hohenhorst, et al.
Cancers|March 10, 2022
Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical CystectomyBenedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
Pageof 11